RE/MAX Holdings Files 8-K: Supplements Merger Proxy, Lists Post-Deal Board

What Happened

• On August 6, 2026 RE/MAX Holdings (RMAX) filed a Form 8-K (Item 8.01) to supplement the joint proxy statement/prospectus and management information circular for its proposed merger with Real (forming “Real REMAX Group”). The supplement (voluntary, without admitting liability) updates the expected board members after closing, committee memberships, and certain financial analyses used in J.P. Morgan’s fairness work. The filing also discloses recent shareholder demand letters and two lawsuits (John Burke v. RE/MAX Holdings, Inc. filed July 22, 2026; Keith Jones v. RE/MAX Holdings, Inc. filed July 23, 2026) alleging disclosure deficiencies; RE/MAX and Real deny the allegations but provided the additional disclosures to avoid potential delay to the transaction.

Key Details

• Expected Real REMAX Group board (as of Aug 6, 2026): 10 expected directors named (e.g., Tamir Poleg (Chair, 50), Erik Carlson (CEO of REMAX, 56), Vikki Bartholomae (independent), Larry Klane (independent, Audit Chair), others). Sharran Srivatsaa named Director Emeritus (advisory only).
• Board committees: Audit Committee chaired by Larry Klane (audit committee financial expert); Compensation Committee chaired by Guy Gamzu; Nominating & Corporate Governance chaired by Laurence Rose.
• Updated financial metrics from J.P. Morgan: peer FV/2026E EBITDA multiples — Compass 11.2x, eXp 15.1x, Real (consensus) 20.5x, REMAX (consensus) 6.1x.
• Discounted cash flow results: implied per-share ranges — REMAX $10.50–$14.00 (vs. unaffected close $6.56 on Apr 23, 2026 and implied offer $13.80 based on 5.150x exchange ratio and Real $2.68 close on Apr 24, 2026); Real $2.50–$3.00 (vs. Real close $2.68 Apr 24). Key inputs cited: REMAX net debt ≈ $320M (12/31/2025); Real cash ≈ $50M (12/31/2025); diluted share counts: REMAX ≈ 39.9M, Real ≈ 256.5M (3/31/2026).
• Pro forma value items: estimated present value of synergies ≈ $233M; Cash Election Consideration ≈ $80M; transaction expenses ≈ $71M. Illustrative analysis showed ~24.3% hypothetical incremental implied value to REMAX Class A holders under the assumptions used.

Why It Matters

• For shareholders, the supplement provides (1) the expected post‑closing leadership team and independent committee structure, (2) updated valuation detail and assumptions behind J.P. Morgan’s analyses, and (3) disclosure of litigation risks that the companies say they deny but are addressing proactively. These items affect governance expectations and help investors evaluate the fairness and rationale of the proposed merger (including the implied per‑share valuations and estimated synergies). The supplement does not change the transaction terms or meeting timing; REMAX and Real continue to recommend voting in favor of the proposals.